Clinical Trial Update: Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating HuCNS-SC for age-related macular degeneration. The study explored safety and early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• HuCNS-SC

Snippet

Sponsor: StemCells, Inc. | Conditions: Age Related Macular Degeneration, Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED